#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Place of inhibin B investigation in clinical andrological praxis


Authors: I. Poršová-Dutoit
Authors‘ workplace: Šilinkův nadační fond Praha, vedoucí prof. MUDr. RNDr. Luboslav Stárka, DrSc.
Published in: Vnitř Lék 2008; 54(11): 1059-1062
Category: Review

Overview

Inhibin B is a gonadal dimeric peptide, produced in men in testicular Sertolli cells. Inhibin B blood level knowledge can be a useful tool in the management of difficult diagnostic problems, such as ambiguous genitalia, the distinction between cryptorchidism and anorchidism and the hypogonadotrophic hypogonadism/delayed puberty differential diagnosis. Inhibin B measurements can help in gonadal dysgenesis evaluation, androgen insensitivity management and also in the diagnosis of some gonadal tumors. In adult men, inhibin B evaluation is helpful in the investigation of male infertility, especially in the judgment of the pro-gnosis of testicular biopsy in in‑vitro fertilization programs. Although commercial kits for inhibin B measurement are available at present, its evaluation is accessible in the Czech Republic for the time being in only very limited number of laboratory centers.

Key words:
inhibin – ambiguous genitalia – cryptorchidism – puberty – gonadal tumors – infertility


Sources

1. Adan L, Couto-Silva AC, Trivin C et al. Congenital gonadotropin deficiency in boys: management during childhood. J Pe-diatr Endocrinol Metab 2004; 17: 149–155.

2. Andersson AM, Toppari J, Haavisto AM et al. Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab 1998; 83: 675–661.

3. Arrigo T, Pirazzoli P, De Sanctis L et al. McCune-Albright syndrome in a boy may present with a monolateral macroorchidism as an early and isolated clinical manifestation. Horm Res 2006; 65: 114–119.

4. Babčová K, Ulčová-Gallová Z, Červenková Z et al. Inhibin B and intraacrosomal proteins in men from the couples with fertility disorders. Čes Gynekol 2006; 71: 111–117.

5. Bauer J, Blumenthal S, Reuber M et al. Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy. Neurology 2004; 62: 243–246.

6. Bohring C, Schroeder-Printzen I, Weidner W et al. Serum levels of inhibin B and follicle-stimulating hormone may predict successful sperm retrieval in men with azoo-spermia who are undergoing testicular sperm extraction. Fertil Steril 2002; 78: 1195–1198.

7. Bouvattier C, Carel JC, Lecointre C et al. Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J Clin Endocrinol Metab 2002; 87: 29–32.

8. Cortes D, Thorup J, Hogdall E et al. The relation of germ cells per tubule in testes, serum inhibin B and FSH in cryptorchid boys. Pediatr Surg Int 2007; 23: 163–169.

9. Coutant R, Lumbroso S, Rey R et al. Macroorchidism due to autonomous hyperfunction of Sertoli cells and G(s)alpha gene mutation: an unusual expression of McCune-Albright syndrome in a prepubertal boy. J Clin Endocrinol Metab 2001; 86: 1778–1781.

10. Červenková Z, Ulčová-Gallová Z, Babcová K et al. Present knowledge on inhibins B and A. Čes gynekol 2006; 71: 79–82.

11. Gray PC, Greenwald J, Blount AL et al. Identification of a binding site on the type II activin receptor for activin and inhibin. J Biol Chem 2000; 275: 3206–3212.

12. Groome NP, Tsigou A, Cranfield M et al. Enzyme immunossays for inhibins, activins and follistations. Mol Cell Endocrinol 2001; 180: 73–77.

13. Hemminki A, Markie D, Tomlinson I et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998; 391: 184–187.

14. Hurwitz JM, Santoro N. Inhibins, activins, and follistatin in the aging female and male. Semin Reprod Med 2004; 22: 209–217.

15. Chada M, Průša R, Bronský J et al. Inhibin B, follicle stimulating hormone, luteinizing hormone and testosterone during childhood and puberty in males: changes in serum concentrations inrelation to age and stage of puberty. Physiol Res 2003; 52: 45–51.

16. Christiansen P, Andersson AM, Skakkebaek NE et al. Serum inhibin B, FSH, LH and testosterone levels before and after human chronic gonadotropin stimulation in prepubertal boys with cryptorchidism. Eur J Endocrinol 2002; 147: 95–101.

17. Christiansen P, Andersson AM, Skakkebaek NE. Longitudinal studies of inhibin B levels in boys and young adults with Klinefelter syndrome. J Clin Endocrinol Metab 2003; 88: 888–891.

18. Iczkowski KA, Bostwick DG, Roche PC et al. Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors. Mod Pathol 1998; 11: 774–779.

19. Illingworth PJ, Groome NP, Byrd W et al. Inhibin‑B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab 1996; 81: 1321–1325.

20. Kubini K, Zachmann M, Albers N et al. Basal inhibin B and the testosterone response to human chorionic gonadotropin correlate in prepubertal boys. J Clin Endocrinol Metab 2000; 85: 134–138.

21. Lahlou N, Fennoy I, Carel JC et al. Inhibin B and anti‑Müllerian hormone, but not testosterone levels, are normal in infants with nonmosaic Klinefelter syndrome. J Clin Endocrinol Metab 2004; 894: 1864–1868.

22. Lahlou N, Roger M. Inhibin B in pubertal development and pubertal disorders. Semin Reprod Med 2004; 22: 165–176.

23. Lefevre H, Bouvattier C, Lahlou N et al. Prepubertal gynecomastia in Peutz-Jeghers syndrome: incomplete penetrance in a familial case and management with an aromatase inhibitor. Eur J Endocrinol 2006; 154: 221–227.

24. Lockwood G. The diagnostic value of inhibin in infertility evaluation. Semin Reprod Med 2004; 22: 195–208.

25. Meachem SJ, Nieschlag E, Simoni M. Inhibin B in male reproduction: pathophysiology and clinical relevance. Eur J Endocrinol 2001; 145: 561–571.

26. Meikle AW. The interrelationships between thyroid dysfunction and hypogonadism in men and boys. Thyroid 2004; 14 (Suppl 1): S17–S25.

27. McCullagh DR. Dual endocrine activity of the testes. Science 1932; 76: 19–20.

28. Misra M, MacLaughlin DT, Donahoe PK et al. Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism. J Clin Endocrinol Metab 2002; 87: 3598–3602.

29. O’Connor AE, de Kretser DM. Inhibins in normal male physiology. Semin Reprod Med 2004; 22: 177–185.

30. Pauli EM, Legro RS, Demers LM et al. Diminished paternity and gonadal function with increasing obesity in men. Fertil Steril 2008; Epub Feb 19.

31. Pierik FH, Abdesselam SA, Vreeburg JT et al. Increased serum inhibin B levels after varicocele treatment. Clin Endocrinol (Oxf) 2001; 54: 775–780.

32. Pigny P, Dewailly D, Racadot A et al. Famille des inhibines et des activines: de I’action endocrine à I’action paracrine. Ann Endocrinol (Paris) 1996; 57: 385–394.

33. Pitteloud N, Hayes FJ, Boepple PA et al. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2002; 87: 152–160.

34. Poršová-Dutoit I. Male hormonal con--traception. Vnitř Lék 2006; 52: 1077–1084.

35. Rajpert-De Meyts E, Jørgensen N, Graem N et al. Expression of anti‑Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 1999; 84: 3836–3844.

36. Rey R. How to evaluate gonadal function in the cryptorchid boy. Lessons from new testicular markers. J Pediatr Endocrinol Metab 2003; 16: 357–364.

37. Rey R, Mebarki F, Forest MG et al. Anti‑müllerian hormone in children with androgen insensitivity. J Clin Endocrinol Metab 1994; 79: 960–964.

38. Risbridger GP, Schmitt JF, Robertson DM. Activins and inhibins in endocrine and other tumors. Endocr Rev 2001; 22: 836–858.

39. Schmiegelow M, Lassen S, Poulsen HS et al. Gonadal status in male survivors following childhood brain tumors. J Clin Endocrinol Metab 2001; 86: 2446–2452.

40. Schneyer A. Inhibins: a historical perspective. Semin Reprod Med 2004; 22: 161–164.

41. Shenker A, Laue L, Kosugi S et al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993; 365: 652–654.

42. Soriano-Guillen L, Mitchell V, Carel JC et al. Activating mutations in the LH receptor gene: a human model of non FSH-dependent inhibin production and germ cell maturation. J Clin Endocrinol Metab 2006; 91: 3041–3047.

43. Vale W, Rivier C, Hsueh A et al. Chemical and biological characterization of the inhibins family of protein hormones. Recent Prog Horm Res 1988; 44: 1–34.

44. Ying SY. Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 1988; 9: 267–293.

45. Young J, Couzinet B, Chanson P et al. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions. J Clin Endocrinol Metab 2000; 85: 3239–3244.

46. Young J, Chanson P, Salenave S et al. Testicular anti‑mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2005; 90: 724–728.

47. Žofková I, Bubeníček P, Sotorník I. Hypogonadism, a serious complication of chronic renal insufficiency. Vnitř Lék 2007; 53: 709–14.

Labels
Diabetology Endocrinology Internal medicine

Article was published in

Internal Medicine

Issue 11

2008 Issue 11

Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#